Leerink Partners Maintains Outperform on McKesson, Raises Price Target to $1070

10/7/2026
Impact: 85
Healthcare

Leerink Partners analyst Michael Cherny has maintained an Outperform rating on McKesson (NYSE: MCK) and raised the price target from $1030 to $1070. This adjustment reflects a positive outlook for the company in the market.

AI summary, not financial advice

Share: